Chromatography is a vital, but costly and complex part of downstream bioprocessing. These challenges have driven Sartomax to enhance efficiency in downstream bioprocessing.
Next-generation therapies utilize large particles, including nucleic acids, viral particles, and exosomes. These biomolecules provide difficulties for traditional chromatography methods, which find it challenging to achieve high quality while ensuring the necessary level of purity.
The industry technology is at a game-changing stage in chromatography. You can lead this evolution and adopt next-generation chromatography lines.
Discover our special chromatography systems and media, designed to accelerate your downstream bioprocess.
